News & Analysis on Clinical Trial Services & Contract Research And Development
The National Cancer Institute (NCI) has revealed the grant recipients for its Cancer Genome Atlas pilot project, which will see three institutions using microarray platforms from Agilent Technologies.
As it steps up its presence in the major clinical trials recruitment hubs in Asia, Quintiles has announced its intention to open a central lab in India to help feed its expanding network of clinical trial operations in the country.
The pharmaceutical sector will have a major influence on how the integration of RFID technology is spread across other industries, according to research firm Venture Development Corporation (VDC).
Two of Pakistan's pharma industry representatives spoke at the CPhI in Paris to raise the profile of this evolving sector of the country's economy.
GlaxoSmithKline (GSK) has told contract sales organisation (CSO) PDI that it will not renew its sales contract with the firm at the end of the year, signalling a devastating $65m-$70m loss in annual revenue for the struggling firm.
Specialty chemicals maker Rohm and Haas has designed new equipments for its drug dissolution testing that it claims can reliably predict the release of oral drugs in vivo, and therefore potentially reduce the amount of animal testing.
The Food and Drug Administration are set to introduce a series of measures that will accelerate the review process for generic drugs, placing a priority on therapies that would address a public health emergency or nationwide shortage.
Using a processing technique described as "revolutionary," DSM is accelerating its activity in the anti-infective arena and targeting new active pharmaceutical ingredients (APIs) that it can develop into cost-competitive generic versions.